123 related articles for article (PubMed ID: 38642579)
1. Neuropilin 2 and soluble neuropilin 2 in neuroendocrine neoplasms.
Gerard L; Patte C; Chardon L; Hervieu V; Payen L; Allio M; Marx C; Clermidy H; Durand A; Mehlen P; Bollard J; Poncet G; Roche C; Gibert B; Walter T
Endocr Relat Cancer; 2024 Jun; 31(6):. PubMed ID: 38642579
[TBL] [Abstract][Full Text] [Related]
2. Neuropilin-2 is an independent prognostic factor for shorter cancer-specific survival in patients with acinar adenocarcinoma of the prostate.
Borkowetz A; Froehner M; Rauner M; Conrad S; Erdmann K; Mayr T; Datta K; Hofbauer LC; Baretton GB; Wirth M; Fuessel S; Toma M; Muders MH
Int J Cancer; 2020 May; 146(9):2619-2627. PubMed ID: 31509606
[TBL] [Abstract][Full Text] [Related]
3. Cytoplasmic neuropilin 2 is associated with metastasis and a poor prognosis in early tongue cancer patients.
Ong HS; Gokavarapu S; Xu Q; Tian Z; Li J; Ji T; Zhang CP
Int J Oral Maxillofac Surg; 2017 Oct; 46(10):1205-1219. PubMed ID: 28602571
[TBL] [Abstract][Full Text] [Related]
4. Neuropilin-2 and Its Transcript Variants Correlate with Clinical Outcome in Bladder Cancer.
Förster S; Givehchi M; Nitschke K; Mayr T; Kilian K; Dutta S; Datta K; Nuhn P; Popovic Z; Muders MH; Erben P
Genes (Basel); 2021 Apr; 12(4):. PubMed ID: 33918816
[TBL] [Abstract][Full Text] [Related]
5. Blood Chromogranin A Is Not Effective as a Biomarker for Diagnosis or Management of Bronchopulmonary Neuroendocrine Tumors/Neoplasms.
Matar S; Malczewska A; Oberg K; Bodei L; Aslanian H; Lewczuk-Myślicka A; Filosso PL; Suarez AL; Kolasińska-Ćwikła A; Roffinella M; Kos-Kudła B; Ćwikła JB; Drozdov IA; Kidd M; Modlin IM
Neuroendocrinology; 2020; 110(3-4):185-197. PubMed ID: 30995665
[TBL] [Abstract][Full Text] [Related]
6. Neuropilin-2 promotes tumourigenicity and metastasis in oesophageal squamous cell carcinoma through ERK-MAPK-ETV4-MMP-E-cadherin deregulation.
Fung TM; Ng KY; Tong M; Chen JN; Chai S; Chan KT; Law S; Lee NP; Choi MY; Li B; Cheung AL; Tsao SW; Qin YR; Guan XY; Chan KW; Ma S
J Pathol; 2016 Jul; 239(3):309-19. PubMed ID: 27063000
[TBL] [Abstract][Full Text] [Related]
7. Neuropilin-2 and its ligand VEGF-C predict treatment response after transurethral resection and radiochemotherapy in bladder cancer patients.
Keck B; Wach S; Taubert H; Zeiler S; Ott OJ; Kunath F; Hartmann A; Bertz S; Weiss C; Hönscheid P; Schellenburg S; Rödel C; Baretton GB; Sauer R; Fietkau R; Wullich B; Krause FS; Datta K; Muders MH
Int J Cancer; 2015 Jan; 136(2):443-51. PubMed ID: 24862180
[TBL] [Abstract][Full Text] [Related]
8. MiR-146a Regulates Migration and Invasion by Targeting NRP2 in Circulating-Tumor Cell Mimicking Suspension Cells.
Do Y; Cho JG; Park JY; Oh S; Park D; Yoo KH; Lee MS; Kwon BS; Kim J; Yang Y
Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33396906
[TBL] [Abstract][Full Text] [Related]
9. Neuropilin 1 and neuropilin 2 co-expression is significantly correlated with increased vascularity and poor prognosis in nonsmall cell lung carcinoma.
Kawakami T; Tokunaga T; Hatanaka H; Kijima H; Yamazaki H; Abe Y; Osamura Y; Inoue H; Ueyama Y; Nakamura M
Cancer; 2002 Nov; 95(10):2196-201. PubMed ID: 12412174
[TBL] [Abstract][Full Text] [Related]
10. Influence of Human Cytomegalovirus Glycoprotein O Polymorphism on the Inhibitory Effect of Soluble Forms of Trimer- and Pentamer-Specific Entry Receptors.
Brait N; Stögerer T; Kalser J; Adler B; Kunz I; Benesch M; Kropff B; Mach M; Puchhammer-Stöckl E; Görzer I
J Virol; 2020 Jul; 94(14):. PubMed ID: 32350071
[TBL] [Abstract][Full Text] [Related]
11. Neuropilin-1 and neuropilin-2 are differentially expressed in human proteinuric nephropathies and cytokine-stimulated proximal tubular cells.
Schramek H; Sarközi R; Lauterberg C; Kronbichler A; Pirklbauer M; Albrecht R; Noppert SJ; Perco P; Rudnicki M; Strutz FM; Mayer G
Lab Invest; 2009 Nov; 89(11):1304-16. PubMed ID: 19736548
[TBL] [Abstract][Full Text] [Related]
12. Early Changes in Circulating Tumor Cells Are Associated with Response and Survival Following Treatment of Metastatic Neuroendocrine Neoplasms.
Khan MS; Kirkwood AA; Tsigani T; Lowe H; Goldstein R; Hartley JA; Caplin ME; Meyer T
Clin Cancer Res; 2016 Jan; 22(1):79-85. PubMed ID: 26199388
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver.
Gray MJ; Van Buren G; Dallas NA; Xia L; Wang X; Yang AD; Somcio RJ; Lin YG; Lim S; Fan F; Mangala LS; Arumugam T; Logsdon CD; Lopez-Berestein G; Sood AK; Ellis LM
J Natl Cancer Inst; 2008 Jan; 100(2):109-20. PubMed ID: 18182619
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of VEGF-C, semaphorin 3F, and neuropilin-2 expression in oral squamous cell carcinomas and their relationship with lymphangiogenesis.
Zhang B; Gao Z; Sun M; Li H; Fan H; Chen D; Zheng J
J Surg Oncol; 2015 Mar; 111(4):382-8. PubMed ID: 25475162
[TBL] [Abstract][Full Text] [Related]
15. The Prognostic Value of Circulating Tumor Cells in Asian Neuroendocrine Tumors.
Hsieh JC; Chen GY; Jhou DD; Chou WC; Yeh CN; Hwang TL; Lin HC; Chu HC; Wang HM; Yen TC; Chen JS; Wu MH
Sci Rep; 2019 Dec; 9(1):19917. PubMed ID: 31882775
[TBL] [Abstract][Full Text] [Related]
16. Long Non-coding RNAs in Pulmonary Neuroendocrine Neoplasms.
Narayanan D; Mandal R; Hardin H; Chanana V; Schwalbe M; Rosenbaum J; Buehler D; Lloyd RV
Endocr Pathol; 2020 Sep; 31(3):254-263. PubMed ID: 32388776
[TBL] [Abstract][Full Text] [Related]
17. [Clinicopathological classification and prognostic factors of gastrointestinal neuroendocrine neoplasms: an analysis of 119 cases].
Ma X; Zhao W; Zhuang C; Wang X; Tu L; Wang M; Sun Y; Cao H
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):997-1001. PubMed ID: 28900989
[TBL] [Abstract][Full Text] [Related]
18. Neuropilin-1 and neuropilin-2 expression in the adenoma-carcinoma sequence of colorectal cancer.
Staton CA; Koay I; Wu JM; Hoh L; Reed MW; Brown NJ
Histopathology; 2013 May; 62(6):908-15. PubMed ID: 23551578
[TBL] [Abstract][Full Text] [Related]
19. Neuropilin-2 promotes lineage plasticity and progression to neuroendocrine prostate cancer.
Wang J; Li J; Yin L; Pu T; Wei J; Karthikeyan V; Lin TP; Gao AC; Wu BJ
Oncogene; 2022 Sep; 41(37):4307-4317. PubMed ID: 35986103
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Threshold for Circulating Tumor Cells in Patients With Pancreatic and Midgut Neuroendocrine Tumors.
Mandair D; Khan MS; Lopes A; Furtado O'Mahony L; Ensell L; Lowe H; Hartley JA; Toumpanakis C; Caplin M; Meyer T
J Clin Endocrinol Metab; 2021 Mar; 106(3):872-882. PubMed ID: 33180939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
